Surgical Science Sweden AB (publ)

OM:SUS 株式レポート

時価総額：SEK 7.5b

Surgical Science Sweden バランスシートの健全性

財務の健全性 基準チェック /56

Surgical Science Swedenの総株主資本はSEK4.5B 、総負債はSEK1.6Mで、負債比率は0.04%となります。総資産と総負債はそれぞれSEK4.9BとSEK420.5Mです。 Surgical Science Swedenの EBIT はSEK142.3Mで、利息カバレッジ比率-6.1です。現金および短期投資はSEK612.9Mです。

主要情報

0.037%

負債資本比率

SEK 1.64m

負債

インタレスト・カバレッジ・レシオ-6.1x
現金SEK 612.89m
エクイティSEK 4.48b
負債合計SEK 420.50m
総資産SEK 4.90b

財務の健全性に関する最新情報

更新なし

Recent updates

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Mar 14
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 01
Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems
author-image

Regulatory Approvals For New Robotics Entrants Will Drive Demand For Simulation Products

Jan 16 Strength in the Educational Products segment and rising demand for simulators indicate potential revenue growth and diversification opportunities.

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Nov 12
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Aug 25
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 21
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Apr 16
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Mar 17
Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 24
Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Nov 29
Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Oct 07
Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

Aug 17
Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

Jun 20
With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

May 17
A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Dec 27
Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Dec 06
Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Sep 08
Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Aug 23
We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

May 26
Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

Apr 29
Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Feb 20
An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jan 11
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Dec 15
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Sep 16
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jul 05
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Jun 08
Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Mar 23
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Mar 02
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Feb 09
Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

財務状況分析

短期負債: SUSの 短期資産 ( SEK1.1B ) が 短期負債 ( SEK283.5M ) を超えています。

長期負債: SUSの短期資産 ( SEK1.1B ) が 長期負債 ( SEK137.0M ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: SUS総負債よりも多くの現金を保有しています。

負債の削減: SUSの負債対資本比率は、過去 5 年間で0%から0.04%に増加しました。

債務返済能力: SUSの負債は 営業キャッシュフロー によって 十分にカバー されています ( 6312.7% )。

インタレストカバレッジ: SUS支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。

貸借対照表

健全な企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2025/05/18 03:10
終値2025/05/16 00:00
収益2025/03/31
年間収益2024/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Surgical Science Sweden AB (publ) 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6

アナリスト機関
Simon JonssonBerenberg
Viktor HögbergDanske Bank
Jonatan AnderssonDNB Markets